Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Critical Care (London, England)|September 2, 2020
The importance of airway and lung microbiome in the critically illIgnacio Martin-Loeches, Robert Dickson, Antoni Torres, et al.Frontiers in Genetics|November 16, 2020
Impact of a <i>Gap Junction Protein Alpha 4</i> Variant on Clinical Disease Phenotype in <i>F508del</i> Homozygous Patients With Cystic FibrosisTabea Horn, Michael Ludwig, Olaf Eickmeier, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|February 14, 2019
Exhaled breath metabolomics reveals a pathogen-specific response in a rat pneumonia model for two human pathogenic bacteria: a proof-of-concept studyPouline M van Oort, Paul Brinkman, Gitte Slingers, et al.Intensive Care Medicine Experimental|December 18, 2020
The predictive validity for mortality of the driving pressure and the mechanical power of ventilationDavid M P van Meenen, Ary Serpa Neto, Frederique Paulus, et al.Annals of Intensive Care|October 27, 2017
Risk stratification using SpO<sub>2</sub>/FiO<sub>2</sub> and PEEP at initial ARDS diagnosis and after 24 h in patients with moderate or severe ARDSLuigi Pisani, Jan-Paul Roozeman, Fabienne D Simonis, et al.Pharmacology Research & Perspectives|November 28, 2022
Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patientsRenate Kos, Anne H Neerincx, Dominic W Fenn, et al.Thorax|June 5, 2021
Untargeted Molecular Analysis of Exhaled Breath as a Diagnostic Test for Ventilator-Associated Lower Respiratory Tract Infections (BreathDx)Pouline Mp van Oort, Tamara M Nijsen, Iain R White, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 21, 2021
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patientsRenate Kos, Paul Brinkman, Anne H Neerincx, et al.Intensive Care Medicine|October 7, 2018
Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohortsAry Serpa Neto, Rodrigo Octavio Deliberato, Alistair E W Johnson, et al.Intensive Care Medicine|April 3, 2023
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIgnacio Martin-Loeches, Antoni Torres, Blin Nagavci, et al.Pageof 7